World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
25594
World Ranking
19031
National Ranking
9490

Overview

Gary L. Davis is affiliated with the University of Florida in the United States. Their research primarily focuses on the field of Medicine with particular attention to various subfields including Infectious Diseases, Epidemiology, Modeling and Simulation, Pathology and Forensic Medicine, and Pulmonary and Respiratory Medicine.

The scientist's work covers multiple topics, such as:

  • Clostridium difficile and Clostridium perfringens research
  • Microscopic Colitis
  • Viral gastroenteritis research and epidemiology
  • COVID-19 epidemiological studies
  • Lymphoma Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Esophageal Cancer Research and Treatment

Notable recent papers authored or coauthored by Gary L. Davis include:

  • "European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)", 2022, Journal of Hospital Infection
  • "AI, IOT, AND AIOT: DEFINITIONS AND IMPACTS ON THE ARTIFICIAL INTELLIGENCE CURRICULUM", 2020, Issues in Information Systems
  • "ACCURACY OF SIMPLE FORECASTING METHODS IN PREDICTING COVID-19 INCIDENCE IN NEW YORK CITY", 2020, Issues in Information Systems
  • "418 | CIRCULATING TUMOR DNA ASSESSMENT IN PATIENTS WITH EARLY-STAGE CLASSICAL HODGKIN LYMPHOMA TREATED WITH COMBINATION OF BRENTUXIMAB VEDOTIN AND NIVOLUMAB", 2025, Hematological Oncology
  • "Feasibility of Holmium Laser Enucleation of the Prostate (HoLEP) After Prior Prostate intervention for benign prostatic hyperplasia (BPH)", 2025, SSRN Electronic Journal

Frequent coauthors in Gary L. Davis's research include:

  • John Stewart
  • Robert Morris
  • Diane Igoche
  • Peyman Mokhtarzadehazar
  • B. Scott Ferguson

Gary L. Davis has contributed to publications in several venues with multiple contributions to Issues in Information Systems, and additional works published in Journal of Hospital Infection, Hematological Oncology, SSRN Electronic Journal, and Urology.

Best Publications

  • Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

    Davis Gl;Balart La;Schiff Er;Lindsay K

  • Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

    Gary L. Davis;Rafael Esteban-Mur;Vinod Rustgi;John Hoefs

  • Significance of serum hepatitis C virus RNA levels in chronic hepatitis C

    J.Y.N Lau;G.L Davis;J Kniffen;K.-P Qian

  • A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

    Robert P. Perrillo;Eugene R. Schiff;Gary L. Davis;Henry C. Bodenheimer

  • Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

    Gary L Davis;Miriam J Alter;Hashem El-Serag;Thierry Poynard

  • Early virologic response to treatment with peginterferon alfa‐2b plus ribavirin in patients with chronic hepatitis C

    Gary L. Davis;John B. Wong;John G. McHutchison;Michael P. Manns

  • Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.

    H C Bodenheimer;K L Lindsay;G L Davis;J H Lewis

  • Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B

    Jay H. Lefkowitch;Eugene R. Schiff;Gary L. Davis;Robert P. Perrillo

  • Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders ☆ ☆☆

    David R. Nelson;Gregory Y. Lauwers;Johnson Y.N. Lau;Gary L. Davis

  • Factors predictive of a beneficial response to therapy of hepatitis C

    G. L. Davis;J. Y. N. Lau

  • Estimates of the Cost-Effectiveness of a Single Course of Interferon-α2b in Patients with Histologically Mild Chronic Hepatitis C

    W G Bennett;Y Inoue;J R Beck;J B Wong

  • Health‐related quality of life in chronic hepatitis C: Impact of disease and treatment response

    John E. Ware;Martha S. Bayliss;Martha S. Bayliss;Michael Mannocchia;Gary L. Davis

  • Impact of Interferon Alfa-2b and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis C

    Thierry Poynard;John McHutchison;Gary L. Davis;Rafael Esteban-Mur

  • The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.

    D. R. Nelson;C. G. Marousis;G. L. Davis;C. M. Rice

  • Spontaneous reactivation of chronic hepatitis B virus infection.

    Gary L. Davis;Jay H. Hoofnagle;Jeanne G. Waggoner

  • Hepatic adenoma and focal nodular hyperplasia: Clinical, pathologic, and radiologic features

    P. Kerlin;G.L. Davis;D.B. McGill;L.H. Weiland

  • Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect.

    David R. Nelson;Zhengkun Tu;Consuelo Soldevila-Pico;Manal Abdelmalek

  • Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients.

    Gary L. Davis;Johnson Y.-N. Lau;Mickie S. Urdea;Paul D. Neuwald

  • Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease

    Kanthi Yalamanchili;Kanthi Yalamanchili;Sherif Saadeh;Göran B. Klintmalm;Linda W. Jennings

  • Activation of Tumor Necrosis Factor-α System in Chronic Hepatitis C Virus Infection

    David R. Nelson;Herbert L. Lim;Constantine G. Marousis;Jane W. S. Fang

Frequent Co-Authors

Johnson Y.N. Lau
Johnson Y.N. Lau Hong Kong Baptist University
Masashi Mizokami
Masashi Mizokami National Center For Global Health and Medicine
Joseph Lau
Joseph Lau Chinese University of Hong Kong
David R. Nelson
David R. Nelson University of Tennessee Health Science Center
Robert G. Gish
Robert G. Gish University of Nevada Reno
John B. Wong
John B. Wong Tufts University
Jules L. Dienstag
Jules L. Dienstag Harvard University
John G. McHutchison
John G. McHutchison Duke University
Mickey S. Urdea
Mickey S. Urdea Halteres Associates
Eugene R. Schiff
Eugene R. Schiff University of Miami

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional medical degree in the USA is just one of many ways to enter the healthcare field. Many students and professionals are now considering flexible online programs that lead to diverse career pathways. For those interested in healthcare management, a health administration degree offers skills to work in hospitals, clinics, or health organizations without direct patient care.

If you want to advance further in healthcare leadership, exploring the mha degree cost may help you find affordable options for your master's. Clinical professionals seeking to elevate their healthcare practice might consider pursuing dnp online programs cheap, which prepare graduates for the highest levels of nursing practice.

Those interested in pharmacy can also benefit from flexible, accredited online programs. The 3-year online pharmd can fast-track students to pharmaceutical careers in a cost-effective way. These online options make healthcare careers more accessible, diverse, and aligned with your personal goals.

Best Scientists Citing Gary L. Davis

Trending Scientists

Recently Published Articles